HitGen Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Trial of HG146 Administered to Participants with Adenoid Cystic Carcinoma (NCT06781567) | HitGen Inc. | 2024-12-13 |
| Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma (NCT04977167) | HitGen Inc. | 2023-07-28 |
| A Study of HG381 Administered to Patients With Advanced Solid Tumors (NCT04998422) | HitGen Inc. | 2021-10-18 |
| A Study of HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma (NCT03710915) | HitGen Inc. | 2019-01-12 |
Track HitGen Inc. automatically
Every clearance here is in the API, with alerts when new ones post.